73 related articles for article (PubMed ID: 36386141)
1. New insights into nucleic acid sensor AIM2: The potential benefit in targeted therapy for cancer.
Cui JZ; Chew ZH; Lim LHK
Pharmacol Res; 2024 Feb; 200():107079. PubMed ID: 38272334
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial Biosynthesis Creates a Novel Aglycone Polyether with High Potency and Low Side Effects Against Bladder Cancer.
Yan P; Wang G; Huang M; Liu Z; Dai C; Hu B; Gu M; Deng Z; Liu R; Wang X; Liu T
Adv Sci (Weinh); 2024 Jun; ():e2404668. PubMed ID: 38935027
[TBL] [Abstract][Full Text] [Related]
3. Identification of a pyroptosis-immune-related lncRNA signature for prognostic and immune landscape prediction in bladder cancer patients.
Zhao F; Jia Z; Xie H
Discov Oncol; 2024 May; 15(1):140. PubMed ID: 38695942
[TBL] [Abstract][Full Text] [Related]
4. The m6A Reader YTHDF2 Promotes Bladder Cancer Progression by Suppressing RIG-I-Mediated Immune Response.
Zhang L; Li Y; Zhou L; Zhou H; Ye L; Ou T; Hong H; Zheng S; Zhou Z; Wu K; Yan Z; Thiery JP; Cui J; Wu S
Cancer Res; 2023 Jun; 83(11):1834-1850. PubMed ID: 36939388
[TBL] [Abstract][Full Text] [Related]
5. Bacillus Calmette-Guérin immunotherapy for genitourinary cancer.
Gandhi NM; Morales A; Lamm DL
BJU Int; 2013 Aug; 112(3):288-97. PubMed ID: 23517232
[TBL] [Abstract][Full Text] [Related]
6. AIM2 inflammasome activation benefits the therapeutic effect of BCG in bladder carcinoma.
Zhou H; Zhang L; Luo W; Hong H; Tang D; Zhou D; Zhou L; Li Y
Front Pharmacol; 2022; 13():1050774. PubMed ID: 36386141
[TBL] [Abstract][Full Text] [Related]
7. Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma.
You J; Li H; Wei Y; Fan P; Zhao Y; Yi C; Guo Q; Yang X
Front Oncol; 2022; 12():881860. PubMed ID: 35847844
[TBL] [Abstract][Full Text] [Related]
8. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign.
Li R; Metcalfe MJ; Tabayoyong WB; Guo CC; Nogueras González GM; Navai N; Grossman HB; Dinney CP; Kamat AM
Eur Urol Oncol; 2019 May; 2(3):286-293. PubMed ID: 31200843
[TBL] [Abstract][Full Text] [Related]
9. Tumor microenvironment and epithelial-mesenchymal transition in bladder cancer: Cytokines in the game?
Martins-Lima C; Chianese U; Benedetti R; Altucci L; Jerónimo C; Correia MP
Front Mol Biosci; 2022; 9():1070383. PubMed ID: 36699696
[TBL] [Abstract][Full Text] [Related]
10. The pathological role of NLRs and AIM2 inflammasome-mediated pyroptosis in damaged blood-brain barrier after traumatic brain injury.
Ge X; Li W; Huang S; Yin Z; Xu X; Chen F; Kong X; Wang H; Zhang J; Lei P
Brain Res; 2018 Oct; 1697():10-20. PubMed ID: 29886252
[TBL] [Abstract][Full Text] [Related]
11. CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes.
Liu Y; Wu Y; Zhang P; Xu C; Liu Z; He C; Liu Y; Kang Z
Front Oncol; 2021; 11():636870. PubMed ID: 33747959
[TBL] [Abstract][Full Text] [Related]
12. Turning up the heat on non-immunoreactive tumors: pyroptosis influences the tumor immune microenvironment in bladder cancer.
Chen X; Chen H; Yao H; Zhao K; Zhang Y; He D; Zhu Y; Cheng Y; Liu R; Xu R; Cao K
Oncogene; 2021 Nov; 40(45):6381-6393. PubMed ID: 34588621
[TBL] [Abstract][Full Text] [Related]
13. 100 years of Bacillus Calmette-Guérin immunotherapy: from cattle to COVID-19.
Lobo N; Brooks NA; Zlotta AR; Cirillo JD; Boorjian S; Black PC; Meeks JJ; Bivalacqua TJ; Gontero P; Steinberg GD; McConkey D; Babjuk M; Alfred Witjes J; Kamat AM
Nat Rev Urol; 2021 Oct; 18(10):611-622. PubMed ID: 34131332
[TBL] [Abstract][Full Text] [Related]
14. Advances in bladder cancer biology and therapy.
Tran L; Xiao JF; Agarwal N; Duex JE; Theodorescu D
Nat Rev Cancer; 2021 Feb; 21(2):104-121. PubMed ID: 33268841
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
